Compound ID | 2098
Synonym(s): Seromycin | orientomycin | oxamycin | tisomycin
Class: Isoxazoline
Spectrum of activity: | Gram-positive |
Details of activity: | Interferes with bacterial cell wall synthesis by competitively inhibiting two enzymes, L-alanine racemase and D-alanine:D-alanine ligase, thereby impairing peptidoglycan formation |
Description: | Natural compound produced by Streptomyces. Used in the treatment of drug resistant tuberculosis; off-patent |
Year first mentioned: | 1955 |
Highest developmental phase: | Approved by FDA in 1964 |
Development status: | Approved |
Chemical structure(s): | |||||||||||
|
|
External links: | |
PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/6234 |
Guide to Pharmacology: | D-cycloserine |
Citations: |
|